NASDAQ: RCELAvita Medical Inc Stock Ownership - Who owns Avita Medical?
Insider buying vs selling
Have Avita Medical Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Robert McNamara | Director | 2025-08-28 | 10,000 | $4.50 | $45.00kBuy |
| David D. Otoole | CFO | 2025-08-26 | 2,000 | $4.52 | $9.04kBuy |
| Robert McNamara | Director | 2025-08-19 | 10,000 | $5.00 | $50.00kBuy |
| David D. Otoole | CFO | 2025-08-12 | 2,000 | $4.81 | $9.62kBuy |
| David D. Otoole | CFO | 2025-05-30 | 1,923 | $4.78 | $9.19kBuy |
| Robert McNamara | Director | 2025-03-06 | 11,000 | $8.30 | $91.30kBuy |
| David D. Otoole | CFO | 2025-02-20 | 1,000 | $9.90 | $9.90kBuy |
| Robert McNamara | Director | 2025-02-20 | 10,000 | $10.09 | $100.90kBuy |
| David D. Otoole | CFO | 2025-02-19 | 1,000 | $10.25 | $10.25kBuy |
| Suzanne Crowe | Director | 2024-12-09 | 486 | $13.15 | $6.39kBuy |
RCEL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RCEL insiders and whales buy or sell their stock.
RCEL Shareholders
What type of owners hold Avita Medical Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 7.17% | 1,895,655 | $7.81M | Institution |
| Vanguard Group Inc | 5.49% | 1,450,367 | $5.98M | Institution |
| Geode Capital Management LLC | 2.34% | 618,342 | $2.55M | Institution |
| State Street Corp | 2.00% | 528,784 | $2.18M | Institution |
| Ubs Group Ag | 1.55% | 409,799 | $1.69M | Institution |
| Michael S. Perry | 1.54% | 406,525 | $1.67M | Insider |
| Opaleye Management Inc | 1.47% | 389,519 | $1.60M | Institution |
| Millennium Management LLC | 1.40% | 369,192 | $1.52M | Institution |
| Northern Trust Corp | 0.98% | 259,597 | $1.07M | Institution |
| Morgan Stanley | 0.84% | 222,193 | $915.44k | Institution |
RCEL vs Medical Device Stocks
Avita Medical Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.